A new study reveals that leukemia stem cells exist in multiple resistant states, explaining why venetoclax fails in AML and highlighting new strategies for precision combination therapies. The post Leukemia Stem Cell Diversity Drives Treatment Resistance in AML appeared first on Inside Precision Medicine .